Literature DB >> 7596958

Prenatal cocaine: seizure susceptibility in rat offspring.

M R de Feo1, D Del Priore, O Mecarelli.   

Abstract

Proconvulsant and convulsant effects of cocaine have been described in various experimental models of epilepsy. We have studied the susceptibility to bicuculline and pentylenetetrazol-induced seizures in developing 10-, 20- and 30-day old rats, gestationally exposed to cocaine. Incidence and latency of appearance of the epileptic manifestations, their evolution toward status epilepticus and successive recovery or death, have been evaluated and compared to the same parameters obtained in control animals of the same ages. Results have demonstrated that 10-day-old rats that had been exposed to cocaine are significantly less sensitive than control animals to the convulsant action of both bicuculline and pentylenetetrazole while no substantial differences between the two groups have been found at the successive ages. It is possible that modifications of various neurotransmitter systems caused by prenatal cocaine exposure modify neuronal excitability at least at early stages of development.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7596958     DOI: 10.1016/1043-6618(95)80060-3

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  2 in total

1.  Roles of heat shock factor 1 in neuronal response to fetal environmental risks and its relevance to brain disorders.

Authors:  Kazue Hashimoto-Torii; Masaaki Torii; Mitsuaki Fujimoto; Akira Nakai; Rachid El Fatimy; Valerie Mezger; Min J Ju; Seiji Ishii; Shih-Hui Chao; Kristen J Brennand; Fred H Gage; Pasko Rakic
Journal:  Neuron       Date:  2014-04-10       Impact factor: 17.173

2.  Maternal epileptic seizure induced by pentylenetetrazol: apoptotic neurodegeneration and decreased GABAB1 receptor expression in prenatal rat brain.

Authors:  Muhammad Imran Naseer; Li Shupeng; Myeong Ok Kim
Journal:  Mol Brain       Date:  2009-06-22       Impact factor: 4.041

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.